You may be eligible to participate in the CALIBRATE Study if you:
- Are male or female, aged 18+
- Have been diagnosed with systemic lupus erythematosus
- Have active proliferative lupus nephritis
- Have previously been treated with either mycophenolate mofetil (CellCept®) or cyclophosphamide (Cytoxan®)
CALIBRATE is no longer enrolling participants.